Skip to main content

Advertisement

ADVERTISEMENT

News

News
01/03/2022
Ambulance call-outs for heart attacks are more common on days when air pollution levels are high, according to new research presented at Euroanaesthesia, the annual meeting of the European Society of Anaesthesiology and Intensive Care...
Ambulance call-outs for heart attacks are more common on days when air pollution levels are high, according to new research presented at Euroanaesthesia, the annual meeting of the European Society of Anaesthesiology and Intensive Care...
Ambulance call-outs for heart...
01/03/2022
Cath Lab Digest
News
01/03/2022
Despite what skeptics say, being kind to oneself is not a New Age fad — and there is research to back it up. Middle-aged women who practiced self-compassion had lower risk of developing cardiovascular disease, irrespective of other...
Despite what skeptics say, being kind to oneself is not a New Age fad — and there is research to back it up. Middle-aged women who practiced self-compassion had lower risk of developing cardiovascular disease, irrespective of other...
Despite what skeptics say, being...
01/03/2022
Cath Lab Digest
News
01/03/2022
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted...
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted...
A cost-effectiveness model based...
01/03/2022
Cath Lab Digest
News
12/23/2021
Imagine visiting the doctor, answering a few basic questions and getting an on-the-spot estimate of whether you'll experience heart failure in the next 30 years. Such a model now exists, thanks to a new Northwestern Medicine study, which...
Imagine visiting the doctor, answering a few basic questions and getting an on-the-spot estimate of whether you'll experience heart failure in the next 30 years. Such a model now exists, thanks to a new Northwestern Medicine study, which...
Imagine visiting the doctor,...
12/23/2021
Cath Lab Digest
News
12/22/2021
Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran), the first and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) with two doses a year, after an...
Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran), the first and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) with two doses a year, after an...
Novartis today announced the US...
12/22/2021
Cath Lab Digest
News
12/21/2021
Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters   CavaClear is a first-in-class FDA-cleared solution for advanced IVC filter removal   It is...
Philips IVC Filter Removal Laser Sheath – CavaClear – is intended to safely ablate tissue to remove embedded IVC filters   CavaClear is a first-in-class FDA-cleared solution for advanced IVC filter removal   It is...
Philips IVC Filter Removal...
12/21/2021
Cath Lab Digest
News
12/21/2021
TRIA Aortic Heart Valve Provided Sustained Improvement in Heart Valve Function to One Year With Good Safety Profile
TRIA Aortic Heart Valve Provided Sustained Improvement in Heart Valve Function to One Year With Good Safety Profile
TRIA Aortic Heart Valve Provided...
12/21/2021
Cath Lab Digest
News
12/20/2021
Thin-walled guiding sheath now available with introducer kit variations and longer lengths
Thin-walled guiding sheath now available with introducer kit variations and longer lengths
Thin-walled guiding sheath now...
12/20/2021
Cath Lab Digest
News
12/20/2021
Edwards Lifesciences announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent (SAPIEN 3 with Alterra) for patients with severe...
Edwards Lifesciences announced it received approval from the U.S. Food and Drug Administration (FDA) for the use of the Edwards SAPIEN 3 transcatheter valve with the Alterra adaptive prestent (SAPIEN 3 with Alterra) for patients with severe...
Edwards Lifesciences announced...
12/20/2021
Cath Lab Digest
News
12/20/2021
NORRISTOWN, Pa., December 20, 2021 --Thubrikar Aortic Valve, Inc., announced that it received approval from a Competent Authority in Poland to conduct initial patient implants with its Optimum Transcatheter Aortic Valve Implantation (TAVI)...
NORRISTOWN, Pa., December 20, 2021 --Thubrikar Aortic Valve, Inc., announced that it received approval from a Competent Authority in Poland to conduct initial patient implants with its Optimum Transcatheter Aortic Valve Implantation (TAVI)...
NORRISTOWN, Pa., December 20,...
12/20/2021
Cath Lab Digest

Advertisement

Advertisement

Advertisement